- Loss of Smell More Common in COVID-19 Than Thought
- Psoriasis Meds Don’t Raise Risk of Severe COVID-19: Study
- Diet Drinks Don’t Do Your Heart Any Favors
- Lockdowns Can Widen Kids’ Waistlines – Here’s How to Curb That
- Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectivenes
- Health Highlights: Oct. 27, 2020
- Kidney Trouble Greatly Raises Odds for Fatal COVID-19
- MRIs Might Be Safe for Patients With Implanted Heart Devices
- More Evidence Masks Slow COVID’s Spread
- Dangerous COVID-19 Syndrome First Seen in Kids Also Strikes Adults
Clinical Trials Update: April 27, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Crohn’s Disease
This study will evaluate an investigational medication for Crohn’s disease. You must be 18 or older and have mild-to-moderate active Crohn’s to qualify.
The research study is in Raleigh, N.C.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/crohn’s_disease.aspx.
—–
Type 2 Diabetes
This study will evaluate an investigational drug. Candidates must be at least 18 and have type 2 diabetes that is inadequately controlled with oral medication.
The research site is in Phoenix, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.
—–
Ulcerative Proctitis
To qualify for this study, you must be 18 or older and have symptoms of ulcerative proctitis, which may include frequent bowel movements, diarrhea, bloody stools, or abdominal discomfort.
The research site is in New York City.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/proctitis.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
